| pubmed-article:17603740 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:17603740 | lifeskim:mentions | umls-concept:C0013227 | lld:lifeskim |
| pubmed-article:17603740 | lifeskim:mentions | umls-concept:C0032659 | lld:lifeskim |
| pubmed-article:17603740 | lifeskim:mentions | umls-concept:C0005586 | lld:lifeskim |
| pubmed-article:17603740 | lifeskim:mentions | umls-concept:C0008300 | lld:lifeskim |
| pubmed-article:17603740 | lifeskim:mentions | umls-concept:C0011847 | lld:lifeskim |
| pubmed-article:17603740 | lifeskim:mentions | umls-concept:C0220812 | lld:lifeskim |
| pubmed-article:17603740 | lifeskim:mentions | umls-concept:C1548605 | lld:lifeskim |
| pubmed-article:17603740 | pubmed:issue | 9 | lld:pubmed |
| pubmed-article:17603740 | pubmed:dateCreated | 2007-8-23 | lld:pubmed |
| pubmed-article:17603740 | pubmed:abstractText | Bipolar disorder is the most expensive mental disorder for US employer health plans. No published studies have examined the impact of comorbid diabetes on the cost of treating bipolar disorder. The objectives of this work were to determine the direct costs incurred by patients with bipolar disorder in a US managed care plan, and to examine the influence (1) of drug therapy regimen on bipolar-related costs, and (2) of diabetes on bipolar-related and all-cause costs. | lld:pubmed |
| pubmed-article:17603740 | pubmed:language | eng | lld:pubmed |
| pubmed-article:17603740 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17603740 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:17603740 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17603740 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:17603740 | pubmed:month | Sep | lld:pubmed |
| pubmed-article:17603740 | pubmed:issn | 0933-7954 | lld:pubmed |
| pubmed-article:17603740 | pubmed:author | pubmed-author:LiHongH | lld:pubmed |
| pubmed-article:17603740 | pubmed:author | pubmed-author:L'ItalienGilb... | lld:pubmed |
| pubmed-article:17603740 | pubmed:author | pubmed-author:CarsonWilliam... | lld:pubmed |
| pubmed-article:17603740 | pubmed:author | pubmed-author:HarleyCarolyn... | lld:pubmed |
| pubmed-article:17603740 | pubmed:author | pubmed-author:Corey-LislePa... | lld:pubmed |
| pubmed-article:17603740 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:17603740 | pubmed:volume | 42 | lld:pubmed |
| pubmed-article:17603740 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:17603740 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:17603740 | pubmed:pagination | 690-7 | lld:pubmed |
| pubmed-article:17603740 | pubmed:meshHeading | pubmed-meshheading:17603740... | lld:pubmed |
| pubmed-article:17603740 | pubmed:meshHeading | pubmed-meshheading:17603740... | lld:pubmed |
| pubmed-article:17603740 | pubmed:meshHeading | pubmed-meshheading:17603740... | lld:pubmed |
| pubmed-article:17603740 | pubmed:meshHeading | pubmed-meshheading:17603740... | lld:pubmed |
| pubmed-article:17603740 | pubmed:meshHeading | pubmed-meshheading:17603740... | lld:pubmed |
| pubmed-article:17603740 | pubmed:meshHeading | pubmed-meshheading:17603740... | lld:pubmed |
| pubmed-article:17603740 | pubmed:meshHeading | pubmed-meshheading:17603740... | lld:pubmed |
| pubmed-article:17603740 | pubmed:meshHeading | pubmed-meshheading:17603740... | lld:pubmed |
| pubmed-article:17603740 | pubmed:meshHeading | pubmed-meshheading:17603740... | lld:pubmed |
| pubmed-article:17603740 | pubmed:meshHeading | pubmed-meshheading:17603740... | lld:pubmed |
| pubmed-article:17603740 | pubmed:meshHeading | pubmed-meshheading:17603740... | lld:pubmed |
| pubmed-article:17603740 | pubmed:meshHeading | pubmed-meshheading:17603740... | lld:pubmed |
| pubmed-article:17603740 | pubmed:meshHeading | pubmed-meshheading:17603740... | lld:pubmed |
| pubmed-article:17603740 | pubmed:meshHeading | pubmed-meshheading:17603740... | lld:pubmed |
| pubmed-article:17603740 | pubmed:meshHeading | pubmed-meshheading:17603740... | lld:pubmed |
| pubmed-article:17603740 | pubmed:meshHeading | pubmed-meshheading:17603740... | lld:pubmed |
| pubmed-article:17603740 | pubmed:meshHeading | pubmed-meshheading:17603740... | lld:pubmed |
| pubmed-article:17603740 | pubmed:meshHeading | pubmed-meshheading:17603740... | lld:pubmed |
| pubmed-article:17603740 | pubmed:meshHeading | pubmed-meshheading:17603740... | lld:pubmed |
| pubmed-article:17603740 | pubmed:year | 2007 | lld:pubmed |
| pubmed-article:17603740 | pubmed:articleTitle | Influence of medication choice and comorbid diabetes: the cost of bipolar disorder in a privately insured US population. | lld:pubmed |
| pubmed-article:17603740 | pubmed:affiliation | i3 Innovus, MN002-0258, 12125 Technology Drive, Eden Prairie, MN 55344, USA. carolyn.harley@i3innovus.com | lld:pubmed |
| pubmed-article:17603740 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:17603740 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
